why choose us

First received: May 14, 2023

Clinical Trial: A Demonstration of the Hair and Scalp Benefits of Duobrii in Scalp Psoriasis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Scalp Psoriasis

Study Type: INTERVENTIONAL


Official Title: A Demonstration of the Hair and Scalp Benefits of 0.045% Tazarotene/0.01% Halobetasol Lotion in Scalp Psoriasis

Brief Summary: The objectives of this research are to demonstrate the following:1.To demonstrate improvement in hair growth and hair appearance following 12 weeks of once daily treatment with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.2.To demonstrate improvement in scalp itch reduction following 12 weeks of once daily treatment with tazarotene/halobetasol lotion in patients with moderate to severe scalp psoriasis.3.To pictorially demonstrate improvement in moderate to severe…

Read more